Board Meeting
The next board meeting for Renalytix Plc - ADR is on 31 Mar 2025 for the purpose of Renalytix PLC Second Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Renalytix Plc - ADR

The latest disclosure was made by Fergus Fleming in Renalytix Plc - ADR where a trade of 25,000 Ords 0.25p done at an average price of $0.1 was reported to US exchanges on Dec. 20, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Fergus Fleming Executive Director,Chief Technical Officer Purchase of securities on an exchange or from another person at price $ 0.10 per share. 20 Dec 2024 25,000 594,481 (0%) 0% 0.1 2,438 Ords 0.25p
Julian Huw Baines Executive Director,Chairman Purchase of securities on an exchange or from another person at price $ 0.08 per share. 10 Dec 2024 23,000 1,848,700 (1%) 0% 0.1 1,955 Ords 0.25p
James Renwick McCullough Executive Director,Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.08 per share. 10 Dec 2024 25,000 3,242,096 (2%) 0% 0.1 2,125 Ords 0.25p
Christopher Harwood Bernard Mills Non-Executive Director Purchase of securities on an exchange or from another person at price $ 0.07 per share. 05 Dec 2024 48,601 14,561,345 (9%) 0% 0.1 3,402 Ords 0.25p
James Renwick McCullough Executive Director,Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.08 per share. 05 Dec 2024 53,300 3,217,096 (2%) 0% 0.1 3,998 Ords 0.25p
Julian Huw Baines Executive Director,Chairman Purchase of securities on an exchange or from another person at price $ 0.07 per share. 04 Dec 2024 23,989 1,825,700 (1%) 0% 0.1 1,739 Ords 0.25p
Christopher Harwood Bernard Mills Non-Executive Director,Chairman Purchase of securities on an exchange or from another person at price $ 0.09 per share. 09 Oct 2024 500,000 14,572,500 (4%) 0% 0.1 45,000 Ords 0.00p
James Renwick McCullough Chairman of the Board and Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.09 per share. 09 Oct 2024 417,710 3,164,096 (0%) 0% 0.1 37,594 Ords 0.00p
Fergus Fleming Chief Technology Officer and Director Purchase of securities on an exchange or from another person at price $ 0.09 per share. 09 Oct 2024 83,542 653,023 (0%) 0% 0.1 7,519 Ords 0.00p
Catherine Havlik Coste Independent Director Purchase of securities on an exchange or from another person at price $ 0.09 per share. 09 Oct 2024 279,866 279,866 (0%) 0% 0.1 25,188 Ords 0.00p
Christopher Harwood Bernard Mills Non-Executive Director,Chairman Purchase of securities on an exchange or from another person at price $ 0.09 per share. 08 Oct 2024 500,000 14,609,946 (4%) 0% 0.1 45,000 Ords 0.00p
Christopher Harwood Bernard Mills Non-Executive Director,Chairman Sale of securities on an exchange or to another person at price $ 0.08 per share. 07 Oct 2024 83,696 14,488,804 (4%) 0% 0.1 6,696 Ords 0.00p
Joel R. Jung Interim Chief Financial Office Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 60,000 60,000 - - Employee Stock Option (right to buy)
Christopher Harwood Bernard Mills Non-Executive Director Purchase of securities on an exchange or from another person at price $ 0.20 per share. 14 Mar 2024 4,000,000 14,072,500 (11%) 3% 0.2 800,000 Ords 0.00p
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures